Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PTCT
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 382 | $60.14 | $23.0K Sale | Form 4 ↗ |
| Oct 14, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 2,118 | $59.52 | $126.1K Sale | Form 4 ↗ |
| Sep 17, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 376 | $68.45 | $25.7K Sale | Form 4 ↗ |
| Sep 17, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 9,624 | $67.83 | $652.8K Sale | Form 4 ↗ |
| Sep 16, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 7,006 | $67.35 | $471.9K Sale | Form 4 ↗ |
| Sep 16, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 2,994 | $66.58 | $199.3K Sale | Form 4 ↗ |
| Sep 10, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 10,000 | $67.34 | $673.4K Sale | Form 4 ↗ |
| Sep 9, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 572 | $68.67 | $39.3K Sale | Form 4 ↗ |
| Sep 9, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 9,428 | $67.79 | $639.1K Sale | Form 4 ↗ |
| Aug 27, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 610 | $72.22 | $44.1K Sale | Form 4 ↗ |
| Aug 27, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 11,890 | $71.55 | $850.7K Sale | Form 4 ↗ |
| Aug 26, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 5,626 | $73.18 | $411.7K Sale | Form 4 ↗ |
| Aug 26, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 6,874 | $72.74 | $500.0K Sale | Form 4 ↗ |
| Aug 20, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 691 | $72.92 | $50.4K Sale | Form 4 ↗ |
| Aug 20, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 2,390 | $71.88 | $171.8K Sale | Form 4 ↗ |
| Aug 20, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 9,419 | $70.78 | $666.7K Sale | Form 4 ↗ |
| Aug 19, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 7,165 | $73.67 | $527.8K Sale | Form 4 ↗ |
| Aug 19, 2026 | Michael Schmertzler Director | PTCT PTC Therapeutics, Inc. | Sale | 5,335 | $72.86 | $388.7K Sale | Form 4 ↗ |
| Aug 17, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 969 | $72.90 | $70.6K Sale | Form 4 ↗ |
| Aug 17, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 1,844 | $72.39 | $133.5K Sale | Form 4 ↗ |
| Aug 4, 2026 | Matthew B. Klein CHIEF EXECUTIVE OFFICER, Director | PTCT PTC Therapeutics, Inc. | Sale | 10,292 | $68.57 | $705.7K Sale | Form 4 ↗ |
| Jul 14, 2026 | Pierre Gravier CHIEF FINANCIAL OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 3,494 | $80.35 | $280.7K Sale | Form 4 ↗ |
| Jul 9, 2026 | Mary L. Smith Director | PTCT PTC Therapeutics, Inc. | Sale | 5,834 | $90.00 | $525.1K Sale | Form 4 ↗ |
| Jul 9, 2026 | Mary L. Smith Director | PTCT PTC Therapeutics, Inc. | Sale | 10,000 | $90.00 | $900.0K Sale | Form 4 ↗ |
| Jul 9, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 2,464 | $90.25 | $222.4K Sale | Form 4 ↗ |
| Jul 7, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 9,288 | $89.44 | $830.7K Sale | Form 4 ↗ |
| Jul 7, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 11,369 | $89.03 | $1.0M Sale | Form 4 ↗ |
| Jul 7, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 3,956 | $87.17 | $344.8K Sale | Form 4 ↗ |
| Jul 6, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 745 | $86.38 | $64.4K Sale | Form 4 ↗ |
| Jul 6, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 645 | $85.84 | $55.4K Sale | Form 4 ↗ |
| Jul 6, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 1,036 | $84.41 | $87.4K Sale | Form 4 ↗ |
| Jul 6, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 387 | $83.10 | $32.2K Sale | Form 4 ↗ |
| Jul 6, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 601 | $86.38 | $51.9K Sale | Form 4 ↗ |
| Jul 6, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 519 | $85.84 | $44.6K Sale | Form 4 ↗ |
| Jul 6, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 833 | $84.41 | $70.3K Sale | Form 4 ↗ |
| Jul 6, 2026 | Mark Elliott Boulding EXEC. VP AND CLO | PTCT PTC Therapeutics, Inc. | Sale | 313 | $83.10 | $26.0K Sale | Form 4 ↗ |
| Jul 6, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 2,474 | $87.03 | $215.3K Sale | Form 4 ↗ |
| Jul 6, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 10,090 | $86.32 | $871.0K Sale | Form 4 ↗ |
| Jul 6, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 8,786 | $85.35 | $749.9K Sale | Form 4 ↗ |
| Jul 6, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 385 | $86.34 | $33.2K Sale | Form 4 ↗ |
| Jul 6, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 426 | $85.28 | $36.3K Sale | Form 4 ↗ |
| Jun 26, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 7,718 | $85.26 | $658.0K Sale | Form 4 ↗ |
| Jun 26, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 412 | $85.23 | $35.1K Sale | Form 4 ↗ |
| Jun 25, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 100 | $87.00 | $8,700 Sale | Form 4 ↗ |
| Jun 25, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 11,337 | $86.51 | $980.8K Sale | Form 4 ↗ |
| Jun 25, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 8,522 | $85.26 | $726.6K Sale | Form 4 ↗ |
| Jun 25, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 419 | $86.39 | $36.2K Sale | Form 4 ↗ |
| Jun 25, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 582 | $85.24 | $49.6K Sale | Form 4 ↗ |
| Jun 24, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 4,922 | $85.03 | $418.5K Sale | Form 4 ↗ |
| Jun 24, 2026 | Neil Gregory Almstead CHIEF TECHNICAL OPS OFFICER | PTCT PTC Therapeutics, Inc. | Sale | 401 | $85.01 | $34.1K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances